Physiological iron-handling protein

Physiological iron-handling proteins represent a coordinated system of molecules responsible for maintaining systemic and cellular iron homeostasis. This group includes transport proteins like transferrin, storage proteins such as ferritin, and the sole known cellular iron exporter, ferroportin (StatPearls: Iron Metabolism, 2023). The system is primarily regulated by the hepatic hormone hepcidin, which controls iron entry into the plasma by inducing the degradation of ferroportin (PubMed: 23348423). These proteins are critical for ensuring sufficient iron for erythropoiesis and metabolic functions while preventing the toxicity associated with free iron-induced oxidative stress (UniProt: P02787). Dysregulation of these proteins is central to the pathogenesis of iron-deficiency anemia and hereditary hemochromatosis (NIH: Iron Fact Sheet, 2023). Pharmacological targeting of this system involves iron replacement therapies to treat deficiency and iron chelators like deferoxamine to manage overload states (PubChem: CID 135398508). Emerging therapies include hepcidin mimetics and ferroportin inhibitors designed to treat conditions like polycythemia vera and beta-thalassemia by restricting iron availability. Overall, these proteins serve as the gatekeepers of iron flux, balancing the body's requirement for this essential metal against its potential for oxidative damage.

Other names

Iron metabolism proteinsIron regulatory proteinsIron transport and storage proteinsIron homeostasis proteins

Iron supplementation, iron chelation, hepcidin agonism, and ferroportin inhibition.